Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Import and export (31)
- Safety monitoring and information (127)
- Compliance and enforcement (33)
- Shortages and supply disruptions (16)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
480 result(s) found, displaying 226 to 250
-
Safety alertsJa Dera 100% Natural Weight Loss Supplement capsules pose a serious risk to your health and should not be taken
-
Safety alertsNo evidence to support routine blood monitoring at this time
-
Safety alertsSlim Fit capsules pose a serious risk to your health and should not be taken
-
Market actionsRecall - risk of adverse events due to unacceptably high level of arsenic
-
Safety alertsUpdate - adverse event monitoring
-
Market actionsThe following medicines (with brand names in brackets) should be returned to a pharmacy: alprazolam (Xanax), cabergoline (Dostinex and Cabaser), mefanamic acid (Ponstan), methotrexate (Methoblastin) and triazolam (Halcion)
-
Market actionsRecall - bottles supplied without child-resistant caps
-
-
-
-
-
-
-
-
-
-
-
-
Safety alertsSafety advisory
-
-
Market actionsRecall for product correction - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall for product correction - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps